trial

Brain Stimulation and Cognitive Training

NCTId NCT03338673
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Completed
Enrollment 12 (actual)
Sponsored by University of Michigan
Primary completion 2019-09-27
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
12 (actual)
Study type
Interventional
Allocation
Randomized
Model
Crossover
Masking
None
Start
2018-10-11
Primary completion
2019-09-27
Eligibility
ALL · 18 Years · 55 Years

Interventions & indications

Drugs
TDCSBrainHQ

Sponsors

University of MichiganLead Sponsor

Investigators

1
Cynthia Burton, PhDPrincipal Investigator

Sites

1 total
Ann Arbor, United States

Facts & assertions

4 sourced
Enrollment
12
Phase
NA
Primary Completion Date
2019-09-27
Status
COMPLETED
relationships
The graph out of here
drug
TDCS
drug
BrainHQ
drug
lead_sponsor
University of Michigan
company
indication
Schizo Affective Disorder
indication
Bipolar Disorder
indication
Psychotic Disorders
indication
investigator
Cynthia Burton, PhD
person